Terminated NCT06949657
This summary needs review. Please check the official study record and contact the research team for details.
In Huzhou Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral Over 60 Years
Countries China
Sponsor Third People's Hospital, Huzhou City, Zhejiang Province, China
Condition Schizophrenia Completed NCT06136390
This summary needs review. Please check the official study record and contact the research team for details.
In Berlin Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 75 Years
Countries Germany
Sponsor Charite University, Berlin, Germany
Condition Schizophrenia Completed NCT04922593
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Luye Pharma Group Ltd.
Condition Schizophrenia Terminated NCT03741751
This summary needs review. Please check the official study record and contact the research team for details.
In St Louis Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Washington University School of Medicine
Condition Schizophrenia Active Not Recruiting NCT04318977
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Brno Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 75 Years
Countries Czechia, Germany
Sponsor University of Regensburg
Condition Schizophrenia Completed NCT07111689
This summary needs review. Please check the official study record and contact the research team for details.
In Ankara Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries Türkiye
Sponsor Saglik Bilimleri Universitesi
Condition Schizophrenia Completed NCT06886607
This summary needs review. Please check the official study record and contact the research team for details.
In Konya Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 25 Years to 55 Years
Countries Türkiye
Sponsor Selcuk University
Condition Schizophrenia Active Not Recruiting NCT04033679
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other Over 18 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Schizophrenia Completed EUCTR 2021-003588-85
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Belgium Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries Belgium
Sponsor UCLouvain
Condition Schizophrenia Completed EUCTR 2004-000830-35
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Italy Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries Italy
Sponsor JANSSEN-CILAG
Condition Schizophrenia Completed EUCTR 2015-004483-11
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Belgium Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries Belgium, Netherlands
Sponsor University Medical Center Utrecht
Condition Schizophrenia Terminated EUCTR 2016-000565-23
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Denmark Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug
Countries Denmark
Sponsor
Condition Schizophrenia